UNSPSC 51432403: Zofenopril

This classification denotes an ace inhibitor with the molecular formula C22H23NO4S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 290ZY759PI chemically known as r-proline, 1-(3-(benzoylthio)-2-methyl-1-oxopropyl)-4-(phenylthio)-, (1(r*),2.alpha.,4.alpha.)- but generally known as zofenopril, which bears US NIH Compound Identifier 92400. European Medicines Agency schedules Zofenopril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00170MIG.

UNSPSC 51432403 Zofenopril is a Commodity code covering pharmaceutical products used in emergency medical response. State and local governments procure advanced life support medications under this code for deployment by fire rescue services and emergency response units. The City of Tampa's recent solicitation for Advanced Life Support Medications (Bid No. 26-P-00188) illustrates the scope: sealed-bid procurement of specific injectable medications including labetalol, epinephrine, adenosine, and diltiazem for Tampa Fire Rescue in Hillsborough County, Florida. Issuing bodies under this code include municipal fire departments and emergency services operating through city purchasing offices. Vendors must supply medications meeting strict shelf-life requirements (nine months or more expiration from acceptance), warrant freedom from defects for a minimum of one year, and arrange pickup and replacement of expired stock before expiration. Delivery timelines are tight—ten calendar days of order receipt—and pricing must be firm and all-inclusive of shipping and applicable taxes.

The Tampa solicitation (Bid No. 26-P-00188, IFB with an April 8, 2026 response date and an estimated contract value of $40,000.00) originated from Florida. The contract term runs one year from award with two optional one-year renewals plus unilateral extension rights for up to three additional 30-day periods. The City of Tampa designated the solicitation with a Small Local Business Enterprise (SLBE) sheltered market status offering a 5 percent bid discount for SLBE participation capped at $10,000. Vendors must submit comprehensive accessibility documentation conforming to WCAG 2.2 Level AA and Section 508 standards and provide OSHA-compliant Safety Data Sheets for all medications supplied. Award is to be made to the lowest responsive, responsible bidder within 120 days of bid opening.